dactinomycin has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baxter, PA; Berens, ME; Brabetz, S; Chau, LQ; Cho, YJ; Crawford, JR; Dimmock, DP; Du, Y; Ecker, J; Finlay, D; Garancher, A; Gröbner, S; Henderson, JJ; Jensen, J; Juarez, EF; Kogiso, M; Kool, M; Levy, ML; Li, XN; Malicki, D; Mesirov, JP; Milde, T; Nahas, SA; Olson, JM; Pfister, SM; Qi, L; Reardon, B; Reyes, I; Rusert, JM; Seker-Cin, H; Serrano, J; Snuderl, M; Tacheva-Grigorova, SK; Tamayo, P; Udaka, YT; Van Allen, EM; Vuori, K; Wahab, S; Wechsler-Reya, RJ; Wong, TC | 1 |
| Bender, S; Jones, DT; Kool, M; Korshunov, A; Kulozik, AE; Lichter, P; Milde, T; Müller, S; Pajtler, KW; Peter Collins, V; Pfister, SM; Schlotter, M; Tzaridis, T; Witt, H; Witt, O; Wittmann, A | 1 |
| Billups, C; Cheshire, PJ; Fouladi, M; Friedman, HS; Houghton, PJ; Leggas, M; Peterson, JK; Stewart, CF; Woo, MH | 1 |
| Kovacs, SG; Nathanson, L | 1 |
| Bailey, C; Littman, P; Rosenstock, JG | 1 |
5 other study(ies) available for dactinomycin and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cerebellar Neoplasms; Child; Dactinomycin; Exome Sequencing; Gene Expression Regulation, Neoplastic; High-Throughput Screening Assays; Humans; Male; Medulloblastoma; Mice, Inbred NOD; Mutation; Polymorphism, Single Nucleotide; Precision Medicine; Xenograft Model Antitumor Assays | 2020 |
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dactinomycin; DNA Mutational Analysis; Ependymoma; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Immunohistochemistry; Medulloblastoma; Mice; Neurons; Piperazines; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-mdm2; Stem Cells; Transcription Factor RelA; Treatment Outcome; Tumor Suppressor Protein p53 | 2016 |
Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Chromatography, High Pressure Liquid; Cyclophosphamide; Dacarbazine; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Glioblastoma; Glioma; Humans; Medulloblastoma; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Mice, SCID; Neoplasms; Neuroblastoma; Neuroectodermal Tumors, Primitive; Radiation Chimera; Random Allocation; Rhabdoid Tumor; Rhabdomyosarcoma, Embryonal; Sesquiterpenes; Tumor Cells, Cultured; Vincristine; Xenograft Model Antitumor Assays | 2002 |
Chemotherapeutic response in metastatic medulloblastoma: report of two cases and a review of the literature.
Topics: Adolescent; Adult; Bone Neoplasms; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Medulloblastoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Semustine; Vincristine | 1978 |
Radiation myelitis following craniospinal irradiation with concurrent actinomycin-D therapy.
Topics: Adolescent; Brain Neoplasms; Child; Dactinomycin; Humans; Male; Medulloblastoma; Myelitis; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Time Factors | 1978 |